PharmX Technologies (ASX:PHX) 1-Year Share Buyback Ratio: -10.20% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PharmX Technologies 1-Year Share Buyback Ratio?

PharmX Technologies ASX:PHX +2.35% 1-Year Share Buyback Ratio is -10.20 as of Jun. 2026. Among 388 Healthcare Providers & Services companies, PharmX Technologies ranks worse than 73.45% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. PharmX Technologies's current 1-Year Share Buyback Ratio was -10.20%.

ASX:PHX's 1-Year Share Buyback Ratio is ranked worse than
73.45% of 388 companies
in the Healthcare Providers & Services industry
Industry Median: -1.25 vs ASX:PHX: -10.20

PharmX Technologies  (ASX:PHX) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

PharmX Technologies 1-Year Share Buyback Ratio Related Terms

ASX:PHX vs VEEV, BTSG, TEM: 1-Year Share Buyback Ratio Comparison

For the Health Information Services subindustry, PharmX Technologies's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmX Technologies 1-Year Share Buyback Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's 1-Year Share Buyback Ratio falls into.


PharmX Technologies 1-Year Share Buyback Ratio Calculation

PharmX Technologies's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2025 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Jun. 2025 )
=(598.507 - 659.457) / 598.507
=-10.2%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -10.20 mean?
PharmX Technologies (ASX:PHX) has a 1-Year Share Buyback Ratio of -10.20 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for PharmX Technologies and its competitors. According to the industry distribution chart, PharmX Technologies ranks #285 out of 388 companies in the Healthcare Providers & Services industry, placing it in the top 73.5%.
Is PharmX Technologies' 1-Year Share Buyback Ratio too high?
PharmX Technologies' current 1-Year Share Buyback Ratio is -10.20. Based on the distribution chart, PharmX Technologies ranks #285 out of 388 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does PharmX Technologies' 1-Year Share Buyback Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, PharmX Technologies ranks #285 out of 388 companies for 1-Year Share Buyback Ratio. This places PharmX Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 1-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for PharmX Technologies and its competitors. PharmX Technologies's current 1-Year Share Buyback Ratio is -10.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmX Technologies stock overvalued right now?
Based on GuruFocus' analysis, PharmX Technologies (ASX:PHX) is currently considered Fairly Valued. The stock's GF Value™ is A$0.08, compared to a current price of A$0.09 — trading 8.7% above its estimated fair value. The current 1-Year Share Buyback Ratio is -10.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For PharmX Technologies (ASX:PHX), the current 1-Year Share Buyback Ratio is -10.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmX Technologies Business Description

Address 17 Castlereagh Street, Suite 11.02, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.